🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I/II trial studies the best dose and side effects of mogamulizum...
Status
Completed
Location
University of California Davis Comprehensive Cancer Center
Start Date
2018-10-24
Trial ID
NCT03309878
Treatments Being Tested
Background: Adult T-cell leukemia/lymphoma (ATLL) and mycosis fungoides/Se...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2020-02-26
Trial ID
NCT04185220
Treatments Being Tested
This is a non-interventional cohort study evaluating non-relapse mortality ...
Status
Recruiting
Location
CIBMTR
Start Date
2019-09-10
Trial ID
NCT04014374
The purpose of this study is to investigate safety, pharmacokinetics, effec...
Status
Unknown
Location
Aichi Medical University
Start Date
2013-02
Trial ID
NCT01929486
Treatments Being Tested
This phase Ib/II trial investigates the side effects of mogamulizumab and e...
Status
Terminated
Location
Emory University Hospital
Start Date
2021-04-21
Trial ID
NCT04676087
Treatments Being Tested
Mogamulizumab in Combination with MEDI4736 (Durvalumab) and Mogamulizumab i...
Status
Completed
Location
The Angeles Clinic
Start Date
2014-11-26
Trial ID
NCT02301130
Treatments Being Tested
The purpose of this study is to determine that no significant safety issues...
Status
Terminated
Location
Research Site
Start Date
2011-12
Trial ID
NCT01514981
This is an open label, single center, non-randomized dose de-escalation pha...
Status
Suspended
Location
University of Alabama at Birmingham
Start Date
2023-05-01
Trial ID
NCT05414500
Treatments Being Tested
This phase Ib/II trial identifies the best dose and possible benefits and/o...
Status
Terminated
Location
City of Hope Comprehensive Cancer Center
Start Date
2021-04-06
Trial ID
NCT04541017
This is an open label, single arm, single-center, pilot study of concurrent...
Status
Suspended
Location
Moffitt Cancer Center
Start Date
2024-01-18
Trial ID
NCT06235281
Treatments Being Tested